Proposal for various pharmaceuticals

PHARMAC is seeking feedback on a proposal for various pharmaceuticals (including new listings, amendments to funding restrictions and a delisting) ...

Read more →

Drug Utilisation Sub Committee outcome statements - February 2015

The outcome statements from the February 2015 Drug Utilisation Sub Committee meeting are now available on the PBS website. ...

Read more →

AbbVie's Holkira Pak now reimbursed in Ontario

AbbVie, a global biopharmaceutical company, today announced that the Common Drug Review (CDR) has posted the Canadian Drug Expert Committee ...

Read more →

Hepatitis C drug delayed by NHS due to high cost

The NHS is to delay the introduction of a highly expensive drug that can save the lives of people infected ...

Read more →

New NICE knockback for Celgene myeloma drug

The National Institute for Health and Clinical Excellence is consulting once again on the use of Celgene’s Revlimid (lenalidomide) in ...

Read more →

New Zealand Pharmaceutical Schedule - February 2014 update

[:content [\1 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \space \T \h \e \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \u \p \d \a \t \e \space \t \o \space \t \h \e \space \N \e \w \space \Z \e \a \l \a \n \d \space \P \h \a \r \m \a \c \e \u \t \i \c \a \l \space \S \c \h \e \d \u \l \e \space \i \s \space \o \u \t \space \a \n \d \space \n \o \w \space \i \n \space \e \f \f \e \c \t \. " ..."]]
Read more →

France to back Roche cancer drug as cheaper eye treatment

The French government, looking to cut healthcare costs, plans to authorize the use of Roche cancer drug Avastin (bevacizumab) as ...

Read more →

Germany's IQWiG has found that pertuzumab (Perjeta) has significant added value in certain patients with advanced breast cancer

[:content [\P \e \r \t \u \z \u \m \a \b \space \( \P \e \r \j \e \t \a \) \  \w \a \s \space \l \a \u \n \c \h \e \d \space \i \n \space \G \e \r \m \a \n \y \space \i \n \  \M \a \r \c \h \space \2 \0 \1 \3 \space \f \o \r \space \u \s \e \  \a \s \space \a \d \j \u \n \c \t \i \v \e \space \t \h \e \r \a \p \y \space \b \y \space \c \e \r \t \a \i \n \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \a \d \v \a \n \c \e \d \  \H \E \R \2 \- \p \o \s \i \t \i \v \e \space \b \r \e \a \s \t \space \c \a \n \c \e \r \. \  " ..."]]
Read more →

CADTH lecture series – Dr. Murray Krahn

CADTH is hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of ...

Read more →

Eisai withdraws epilepsy drug Fycompa in Germany over price disagreement

[:content [\E \i \s \a \i \space \h \a \s \space \s \a \i \d \  \t \h \a \t \space \i \t \space \w \i \l \l \space \t \e \m \p \o \r \a \r \i \l \y \space \s \u \s \p \e \n \d \space \s \a \l \e \s \space \o \f \space \F \y \c \o \m \p \a \space \( \p \e \r \a \m \p \a \n \e \l \) \space \i \n \space \G \e \r \m \a \n \y \space \a \s \space \i \t \space \\ \" \i \s \space \u \n \a \b \l \e \space \t \o \space \a \c \c \e \p \t \space \t \h \e " ..."]]
Read more →

Teriflunomide in multiple sclerosis: added benefit not proven

[:content [\T \e \r \i \f \l \u \n \o \m \i \d \e \space \( \A \u \b \a \g \i \o \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \a \d \u \l \t \s \space \w \i \t \h \space \r \e \l \a \p \s \i \n \g \space \r \e \m \i \t \t \i \n \g \space \m \u \l \t \i \p \l \e \space \s \c \l \e \r \o \s \i \s \. \space \I \n \space \a \n \space \e \a \r \l \y " ..."]]
Read more →

Call for patient input

CADTH has received notice of a pending submission from Cubist for Sivextro (tedizolid phosphate) for patients with an acute bacterial skin and ...

Read more →

UK likes the look of EMA quicker approvals pilot

UK trade associations, politicians, payors and patients have met with the European Medicines Agency to discuss the pros and cons ...

Read more →

Process changes for end of life and very rare conditions

[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \  " ..."]]
Read more →

Rejected prostate cancer drug 'extends life'

The drug abiraterone can add four months to the lives of men with advanced prostate cancer if given before chemotherapy, ...

Read more →